
Seven Quantinuum Directors Buy the Same Day as a Genomics Specialist and Three Industrial Board Members: Deep Tech Commercial Traction Is Already Here
A synchronized seven-person board cluster at Quantinuum dropped $20M collectively on June 5, the same week a genomics specialist director added $11M to GeneDx and three INNIO directors bought in tandem. These insiders sit inside the engine rooms of quantum computing, precision diagnostics, and energy transition hardware. They are seeing commercial pipelines that the market is still pricing as speculative.


































